Advertisement
Innate Pharma S.A. (IPHYF)
OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Follow
As of 03:00PM EST. Market open.
| Previous Close | 0.0000 |
| Open | 2.1300 |
| Bid | 1.3100 x 40000 |
| Ask | 2.2800 x 40000 |
| Day's Range | 2.2000 - 2.2000 |
| 52 Week Range | 1.2800 - 2.8950 |
| Volume | |
| Avg. Volume | 65 |
| Market Cap | 140.685M |
| Beta (5Y Monthly) | 0.87 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4500 |
| Earnings Date | Sep 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Business WireInnate Pharma Highlights Data From Its Innovative Oncology Portfolio Selected for the SITC Annual Meeting 2024
MARSEILLE, France, November 08, 2024--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that new preclinical data supporting the clinical development of its proprietary next generation antibody-drug conjugate (ADC) and innovative tetra-specific ANKET® will be presented at the SITC Annual Meeting 2024.
Business WireInnate Pharma Announces Conference Call and Webcast for Third Quarter 2024 Results and Business Updates
MARSEILLE, France, November 07, 2024--Innate Pharma announces conference call and webcast for third quarter 2024 results and business updates
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.